We are live on ! Find out more
INZY

Inozyme Pharma

Delisted

INZY was delisted on the 30th of June, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
SI
1
Sofinnova Investments
California
$9.8M
DTC
2
Deep Track Capital
Connecticut
$8.71M
RSCM
3
Rock Springs Capital Management
Maryland
$7.52M +$606K +167,562 +6%
VA
4
VR Adviser
New York
$7.26M
PBPIA
5
Pivotal bioVenture Partners Investment Advisor
California
$7.13M
Adage Capital Partners
6
Adage Capital Partners
Massachusetts
$6.96M +$181K +50,000 +2%
NMC
7
NEA Management Company
Maryland
$6.55M
DM
8
Deerfield Management
New York
$5.6M -$2.19M -605,936 -22%
CA
9
CHI Advisors
New York
$5.35M -$136K -37,525 -2%
Vanguard Group
10
Vanguard Group
Pennsylvania
$3.6M -$40.4K -11,153 -0.8%
SFM
11
Sphera Funds Management
Israel
$3.15M +$34.2K +9,458 +0.8%
Janus Henderson Group
12
Janus Henderson Group
$1.91M -$812K -224,379 -24%
MB
13
MPM BioImpact
Massachusetts
$1.77M -$13.9K -3,836 -0.6%
Fidelity Investments
14
Fidelity Investments
Massachusetts
$1.63M -$1.59K -439 -0.1%
BlackRock
15
BlackRock
New York
$1.15M -$7.56K -2,089 -0.5%
LCM
16
Laurion Capital Management
New York
$728K
Geode Capital Management
17
Geode Capital Management
Massachusetts
$626K +$60.6K +16,760 +8%
Millennium Management
18
Millennium Management
New York
$456K -$10.5K -2,908 -2%
UOC
19
UBS O'Connor
Illinois
$444K -$21.2K -5,849 -3%
Renaissance Technologies
20
Renaissance Technologies
New York
$416K +$134K +37,100 +31%
BCM
21
Bridgeway Capital Management
Texas
$358K +$166K +46,000 +53%
Walleye Capital
22
Walleye Capital
New York
$315K +$58.2K +16,087 +16%
Citadel Advisors
23
Citadel Advisors
Florida
$297K -$36.8K -10,179 -8%
State Street
24
State Street
Massachusetts
$205K +$98.8K +27,300 +56%
OMC
25
Overbrook Management Corp
New York
$186K